鼻腔スプレー式インフルエンザワクチンのグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Nasal Spray Influenza Vaccine Market Insights and Forecast to 2027

• レポートコード：QY2112C03895
• 出版社/出版日：QYResearch / 2021年12月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、85ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査資料は鼻腔スプレー式インフルエンザワクチンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。鼻腔スプレー式インフルエンザワクチンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（不活化、生）、用途別市場規模（子供、成人）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・鼻腔スプレー式インフルエンザワクチンの世界市場概要
・メーカー別の競争状況、市場シェア
・鼻腔スプレー式インフルエンザワクチンの種類別市場規模：不活化、生
・鼻腔スプレー式インフルエンザワクチンの用途別市場規模：子供、成人
・北米の鼻腔スプレー式インフルエンザワクチン市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ）
・ヨーロッパの鼻腔スプレー式インフルエンザワクチン市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス）
・アジアの鼻腔スプレー式インフルエンザワクチン市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国）
・中南米の鼻腔スプレー式インフルエンザワクチン市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル）
・中東・アフリカの鼻腔スプレー式インフルエンザワクチン市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア）
・企業情報：AstraZeneca、Cipla、BCHT
・鼻腔スプレー式インフルエンザワクチンのバリューチェーン・販売チャネル分析
・鼻腔スプレー式インフルエンザワクチンの世界市場動向

Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza.

Market Analysis and Insights: Global Nasal Spray Influenza Vaccine Market
The global Nasal Spray Influenza Vaccine market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Nasal Spray Influenza Vaccine Scope and Segment
Nasal Spray Influenza Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nasal Spray Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Inactive
Live

Segment by Application
Child
Adult

By Company
AstraZeneca
Cipla
BCHT

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Nasal Spray Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Nasal Spray Influenza Vaccine Market Size Growth Rate by Type
1.2.2 Inactive
1.2.3 Live
1.3 Market by Application
1.3.1 Global Nasal Spray Influenza Vaccine Market Size Growth Rate by Application
1.3.2 Child
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Nasal Spray Influenza Vaccine Sales Estimates and Forecasts 2016-2027
2.2 Global Nasal Spray Influenza Vaccine Revenue Estimates and Forecasts 2016-2027
2.3 Global Nasal Spray Influenza Vaccine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Nasal Spray Influenza Vaccine Regions by Sales
2.4.1 Global Top Nasal Spray Influenza Vaccine Regions by Sales (2016-2021)
2.4.2 Global Top Nasal Spray Influenza Vaccine Regions by Sales (2022-2027)
2.5 Global Top Nasal Spray Influenza Vaccine Regions by Revenue
2.5.1 Global Top Nasal Spray Influenza Vaccine Regions by Revenue (2016-2021)
2.5.2 Global Top Nasal Spray Influenza Vaccine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Nasal Spray Influenza Vaccine Sales by Manufacturers
3.1.1 Global Top Nasal Spray Influenza Vaccine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Nasal Spray Influenza Vaccine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Nasal Spray Influenza Vaccine Sales in 2020
3.2 Global Nasal Spray Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Top Nasal Spray Influenza Vaccine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Nasal Spray Influenza Vaccine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Nasal Spray Influenza Vaccine Revenue in 2020
3.3 Global Nasal Spray Influenza Vaccine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nasal Spray Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nasal Spray Influenza Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Nasal Spray Influenza Vaccine Sales by Type
4.1.1 Global Nasal Spray Influenza Vaccine Historical Sales by Type (2016-2021)
4.1.2 Global Nasal Spray Influenza Vaccine Forecasted Sales by Type (2022-2027)
4.1.3 Global Nasal Spray Influenza Vaccine Sales Market Share by Type (2016-2027)
4.2 Global Nasal Spray Influenza Vaccine Revenue by Type
4.2.1 Global Nasal Spray Influenza Vaccine Historical Revenue by Type (2016-2021)
4.2.2 Global Nasal Spray Influenza Vaccine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Nasal Spray Influenza Vaccine Revenue Market Share by Type (2016-2027)
4.3 Global Nasal Spray Influenza Vaccine Price by Type
4.3.1 Global Nasal Spray Influenza Vaccine Price by Type (2016-2021)
4.3.2 Global Nasal Spray Influenza Vaccine Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Nasal Spray Influenza Vaccine Sales by Application
5.1.1 Global Nasal Spray Influenza Vaccine Historical Sales by Application (2016-2021)
5.1.2 Global Nasal Spray Influenza Vaccine Forecasted Sales by Application (2022-2027)
5.1.3 Global Nasal Spray Influenza Vaccine Sales Market Share by Application (2016-2027)
5.2 Global Nasal Spray Influenza Vaccine Revenue by Application
5.2.1 Global Nasal Spray Influenza Vaccine Historical Revenue by Application (2016-2021)
5.2.2 Global Nasal Spray Influenza Vaccine Forecasted Revenue by Application (2022-2027)
5.2.3 Global Nasal Spray Influenza Vaccine Revenue Market Share by Application (2016-2027)
5.3 Global Nasal Spray Influenza Vaccine Price by Application
5.3.1 Global Nasal Spray Influenza Vaccine Price by Application (2016-2021)
5.3.2 Global Nasal Spray Influenza Vaccine Price Forecast by Application (2022-2027)

6 North America
6.1 North America Nasal Spray Influenza Vaccine Market Size by Type
6.1.1 North America Nasal Spray Influenza Vaccine Sales by Type (2016-2027)
6.1.2 North America Nasal Spray Influenza Vaccine Revenue by Type (2016-2027)
6.2 North America Nasal Spray Influenza Vaccine Market Size by Application
6.2.1 North America Nasal Spray Influenza Vaccine Sales by Application (2016-2027)
6.2.2 North America Nasal Spray Influenza Vaccine Revenue by Application (2016-2027)
6.3 North America Nasal Spray Influenza Vaccine Market Size by Country
6.3.1 North America Nasal Spray Influenza Vaccine Sales by Country (2016-2027)
6.3.2 North America Nasal Spray Influenza Vaccine Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Nasal Spray Influenza Vaccine Market Size by Type
7.1.1 Europe Nasal Spray Influenza Vaccine Sales by Type (2016-2027)
7.1.2 Europe Nasal Spray Influenza Vaccine Revenue by Type (2016-2027)
7.2 Europe Nasal Spray Influenza Vaccine Market Size by Application
7.2.1 Europe Nasal Spray Influenza Vaccine Sales by Application (2016-2027)
7.2.2 Europe Nasal Spray Influenza Vaccine Revenue by Application (2016-2027)
7.3 Europe Nasal Spray Influenza Vaccine Market Size by Country
7.3.1 Europe Nasal Spray Influenza Vaccine Sales by Country (2016-2027)
7.3.2 Europe Nasal Spray Influenza Vaccine Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Nasal Spray Influenza Vaccine Market Size by Type
8.1.1 Asia Pacific Nasal Spray Influenza Vaccine Sales by Type (2016-2027)
8.1.2 Asia Pacific Nasal Spray Influenza Vaccine Revenue by Type (2016-2027)
8.2 Asia Pacific Nasal Spray Influenza Vaccine Market Size by Application
8.2.1 Asia Pacific Nasal Spray Influenza Vaccine Sales by Application (2016-2027)
8.2.2 Asia Pacific Nasal Spray Influenza Vaccine Revenue by Application (2016-2027)
8.3 Asia Pacific Nasal Spray Influenza Vaccine Market Size by Region
8.3.1 Asia Pacific Nasal Spray Influenza Vaccine Sales by Region (2016-2027)
8.3.2 Asia Pacific Nasal Spray Influenza Vaccine Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Nasal Spray Influenza Vaccine Market Size by Type
9.1.1 Latin America Nasal Spray Influenza Vaccine Sales by Type (2016-2027)
9.1.2 Latin America Nasal Spray Influenza Vaccine Revenue by Type (2016-2027)
9.2 Latin America Nasal Spray Influenza Vaccine Market Size by Application
9.2.1 Latin America Nasal Spray Influenza Vaccine Sales by Application (2016-2027)
9.2.2 Latin America Nasal Spray Influenza Vaccine Revenue by Application (2016-2027)
9.3 Latin America Nasal Spray Influenza Vaccine Market Size by Country
9.3.1 Latin America Nasal Spray Influenza Vaccine Sales by Country (2016-2027)
9.3.2 Latin America Nasal Spray Influenza Vaccine Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Nasal Spray Influenza Vaccine Market Size by Type
10.1.1 Middle East and Africa Nasal Spray Influenza Vaccine Sales by Type (2016-2027)
10.1.2 Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Type (2016-2027)
10.2 Middle East and Africa Nasal Spray Influenza Vaccine Market Size by Application
10.2.1 Middle East and Africa Nasal Spray Influenza Vaccine Sales by Application (2016-2027)
10.2.2 Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Application (2016-2027)
10.3 Middle East and Africa Nasal Spray Influenza Vaccine Market Size by Country
10.3.1 Middle East and Africa Nasal Spray Influenza Vaccine Sales by Country (2016-2027)
10.3.2 Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Nasal Spray Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AstraZeneca Nasal Spray Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Cipla
11.2.1 Cipla Corporation Information
11.2.2 Cipla Overview
11.2.3 Cipla Nasal Spray Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Cipla Nasal Spray Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cipla Recent Developments
11.3 BCHT
11.3.1 BCHT Corporation Information
11.3.2 BCHT Overview
11.3.3 BCHT Nasal Spray Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 BCHT Nasal Spray Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BCHT Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Nasal Spray Influenza Vaccine Value Chain Analysis
12.2 Nasal Spray Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nasal Spray Influenza Vaccine Production Mode & Process
12.4 Nasal Spray Influenza Vaccine Sales and Marketing
12.4.1 Nasal Spray Influenza Vaccine Sales Channels
12.4.2 Nasal Spray Influenza Vaccine Distributors
12.5 Nasal Spray Influenza Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nasal Spray Influenza Vaccine Industry Trends
13.2 Nasal Spray Influenza Vaccine Market Drivers
13.3 Nasal Spray Influenza Vaccine Market Challenges
13.4 Nasal Spray Influenza Vaccine Market Restraints

14 Key Findings in The Global Nasal Spray Influenza Vaccine Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Nasal Spray Influenza Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Inactive
Table 3. Major Manufacturers of Live
Table 4. Global Nasal Spray Influenza Vaccine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Nasal Spray Influenza Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Nasal Spray Influenza Vaccine Sales by Region (2016-2021) & (K Units)
Table 7. Global Nasal Spray Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 8. Global Nasal Spray Influenza Vaccine Sales by Region (2022-2027) & (K Units)
Table 9. Global Nasal Spray Influenza Vaccine Sales Market Share by Region (2022-2027)
Table 10. Global Nasal Spray Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Nasal Spray Influenza Vaccine Revenue Market Share by Region (2016-2021)
Table 12. Global Nasal Spray Influenza Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Nasal Spray Influenza Vaccine Revenue Market Share by Region (2022-2027)
Table 14. Global Nasal Spray Influenza Vaccine Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Nasal Spray Influenza Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Global Nasal Spray Influenza Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Nasal Spray Influenza Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Nasal Spray Influenza Vaccine Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Nasal Spray Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Nasal Spray Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Spray Influenza Vaccine as of 2020)
Table 21. Nasal Spray Influenza Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Nasal Spray Influenza Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Nasal Spray Influenza Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nasal Spray Influenza Vaccine Sales by Type (2016-2021) & (K Units)
Table 26. Global Nasal Spray Influenza Vaccine Sales by Type (2022-2027) & (K Units)
Table 27. Global Nasal Spray Influenza Vaccine Sales Share by Type (2016-2021)
Table 28. Global Nasal Spray Influenza Vaccine Sales Share by Type (2022-2027)
Table 29. Global Nasal Spray Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Nasal Spray Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Nasal Spray Influenza Vaccine Revenue Share by Type (2016-2021)
Table 32. Global Nasal Spray Influenza Vaccine Revenue Share by Type (2022-2027)
Table 33. Nasal Spray Influenza Vaccine Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Nasal Spray Influenza Vaccine Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Nasal Spray Influenza Vaccine Sales by Application (2016-2021) & (K Units)
Table 36. Global Nasal Spray Influenza Vaccine Sales by Application (2022-2027) & (K Units)
Table 37. Global Nasal Spray Influenza Vaccine Sales Share by Application (2016-2021)
Table 38. Global Nasal Spray Influenza Vaccine Sales Share by Application (2022-2027)
Table 39. Global Nasal Spray Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Nasal Spray Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Nasal Spray Influenza Vaccine Revenue Share by Application (2016-2021)
Table 42. Global Nasal Spray Influenza Vaccine Revenue Share by Application (2022-2027)
Table 43. Nasal Spray Influenza Vaccine Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Nasal Spray Influenza Vaccine Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Nasal Spray Influenza Vaccine Sales by Type (2016-2021) & (K Units)
Table 46. North America Nasal Spray Influenza Vaccine Sales by Type (2022-2027) & (K Units)
Table 47. North America Nasal Spray Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Nasal Spray Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Nasal Spray Influenza Vaccine Sales by Application (2016-2021) & (K Units)
Table 50. North America Nasal Spray Influenza Vaccine Sales by Application (2022-2027) & (K Units)
Table 51. North America Nasal Spray Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Nasal Spray Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Nasal Spray Influenza Vaccine Sales by Country (2016-2021) & (K Units)
Table 54. North America Nasal Spray Influenza Vaccine Sales by Country (2022-2027) & (K Units)
Table 55. North America Nasal Spray Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Nasal Spray Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Nasal Spray Influenza Vaccine Sales by Type (2016-2021) & (K Units)
Table 58. Europe Nasal Spray Influenza Vaccine Sales by Type (2022-2027) & (K Units)
Table 59. Europe Nasal Spray Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Nasal Spray Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Nasal Spray Influenza Vaccine Sales by Application (2016-2021) & (K Units)
Table 62. Europe Nasal Spray Influenza Vaccine Sales by Application (2022-2027) & (K Units)
Table 63. Europe Nasal Spray Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Nasal Spray Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Nasal Spray Influenza Vaccine Sales by Country (2016-2021) & (K Units)
Table 66. Europe Nasal Spray Influenza Vaccine Sales by Country (2022-2027) & (K Units)
Table 67. Europe Nasal Spray Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Nasal Spray Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Nasal Spray Influenza Vaccine Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Nasal Spray Influenza Vaccine Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Nasal Spray Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Nasal Spray Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Nasal Spray Influenza Vaccine Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Nasal Spray Influenza Vaccine Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Nasal Spray Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Nasal Spray Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Nasal Spray Influenza Vaccine Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Nasal Spray Influenza Vaccine Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Nasal Spray Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Nasal Spray Influenza Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Nasal Spray Influenza Vaccine Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Nasal Spray Influenza Vaccine Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Nasal Spray Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Nasal Spray Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Nasal Spray Influenza Vaccine Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Nasal Spray Influenza Vaccine Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Nasal Spray Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Nasal Spray Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Nasal Spray Influenza Vaccine Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Nasal Spray Influenza Vaccine Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Nasal Spray Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Nasal Spray Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Nasal Spray Influenza Vaccine Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Nasal Spray Influenza Vaccine Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Nasal Spray Influenza Vaccine Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Nasal Spray Influenza Vaccine Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Nasal Spray Influenza Vaccine Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Nasal Spray Influenza Vaccine Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Major Businesses
Table 107. AstraZeneca Nasal Spray Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. AstraZeneca Nasal Spray Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. AstraZeneca Recent Developments
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Major Businesses
Table 112. Cipla Nasal Spray Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Cipla Nasal Spray Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Cipla Recent Developments
Table 115. BCHT Corporation Information
Table 116. BCHT Description and Major Businesses
Table 117. BCHT Nasal Spray Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. BCHT Nasal Spray Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. BCHT Recent Developments
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Nasal Spray Influenza Vaccine Distributors List
Table 123. Nasal Spray Influenza Vaccine Customers List
Table 124. Nasal Spray Influenza Vaccine Market Trends
Table 125. Nasal Spray Influenza Vaccine Market Drivers
Table 126. Nasal Spray Influenza Vaccine Market Challenges
Table 127. Nasal Spray Influenza Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Nasal Spray Influenza Vaccine Product Picture
Figure 2. Global Nasal Spray Influenza Vaccine Market Share by Type in 2020 & 2027
Figure 3. Inactive Product Picture
Figure 4. Live Product Picture
Figure 5. Global Nasal Spray Influenza Vaccine Market Share by Application in 2020 & 2027
Figure 6. Child
Figure 7. Adult
Figure 8. Nasal Spray Influenza Vaccine Report Years Considered
Figure 9. Global Nasal Spray Influenza Vaccine Sales 2016-2027 (K Units)
Figure 10. Global Nasal Spray Influenza Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Nasal Spray Influenza Vaccine Revenue 2016-2027 (US$ Million)
Figure 12. Global Nasal Spray Influenza Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Nasal Spray Influenza Vaccine Sales Market Share by Region (2016-2021)
Figure 14. Global Nasal Spray Influenza Vaccine Sales Market Share by Region (2022-2027)
Figure 15. North America Nasal Spray Influenza Vaccine Sales YoY (2016-2027) & (K Units)
Figure 16. North America Nasal Spray Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Nasal Spray Influenza Vaccine Sales YoY (2016-2027) & (K Units)
Figure 18. Europe Nasal Spray Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Nasal Spray Influenza Vaccine Sales YoY (2016-2027) & (K Units)
Figure 20. Asia-Pacific Nasal Spray Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Nasal Spray Influenza Vaccine Sales YoY (2016-2027) & (K Units)
Figure 22. Latin America Nasal Spray Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Nasal Spray Influenza Vaccine Sales YoY (2016-2027) & (K Units)
Figure 24. Middle East & Africa Nasal Spray Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Nasal Spray Influenza Vaccine Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Nasal Spray Influenza Vaccine Revenue in 2020
Figure 27. Nasal Spray Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Nasal Spray Influenza Vaccine Sales Market Share by Type (2016-2027)
Figure 29. Global Nasal Spray Influenza Vaccine Revenue Market Share by Type (2016-2027)
Figure 30. Global Nasal Spray Influenza Vaccine Sales Market Share by Application (2016-2027)
Figure 31. Global Nasal Spray Influenza Vaccine Revenue Market Share by Application (2016-2027)
Figure 32. North America Nasal Spray Influenza Vaccine Sales Market Share by Type (2016-2027)
Figure 33. North America Nasal Spray Influenza Vaccine Revenue Market Share by Type (2016-2027)
Figure 34. North America Nasal Spray Influenza Vaccine Sales Market Share by Application (2016-2027)
Figure 35. North America Nasal Spray Influenza Vaccine Revenue Market Share by Application (2016-2027)
Figure 36. North America Nasal Spray Influenza Vaccine Sales Share by Country (2016-2027)
Figure 37. North America Nasal Spray Influenza Vaccine Revenue Share by Country (2016-2027)
Figure 38. United States Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Nasal Spray Influenza Vaccine Sales Market Share by Type (2016-2027)
Figure 41. Europe Nasal Spray Influenza Vaccine Revenue Market Share by Type (2016-2027)
Figure 42. Europe Nasal Spray Influenza Vaccine Sales Market Share by Application (2016-2027)
Figure 43. Europe Nasal Spray Influenza Vaccine Revenue Market Share by Application (2016-2027)
Figure 44. Europe Nasal Spray Influenza Vaccine Sales Share by Country (2016-2027)
Figure 45. Europe Nasal Spray Influenza Vaccine Revenue Share by Country (2016-2027)
Figure 46. Germany Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 47. France Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Nasal Spray Influenza Vaccine Sales Market Share by Type (2016-2027)
Figure 52. Asia Pacific Nasal Spray Influenza Vaccine Revenue Market Share by Type (2016-2027)
Figure 53. Asia Pacific Nasal Spray Influenza Vaccine Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Nasal Spray Influenza Vaccine Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Nasal Spray Influenza Vaccine Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Nasal Spray Influenza Vaccine Revenue Share by Region (2016-2027)
Figure 57. China Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 60. India Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 61. Australia Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 62. China Taiwan Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 63. Indonesia Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 64. Thailand Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 65. Malaysia Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 66. Latin America Nasal Spray Influenza Vaccine Sales Market Share by Type (2016-2027)
Figure 67. Latin America Nasal Spray Influenza Vaccine Revenue Market Share by Type (2016-2027)
Figure 68. Latin America Nasal Spray Influenza Vaccine Sales Market Share by Application (2016-2027)
Figure 69. Latin America Nasal Spray Influenza Vaccine Revenue Market Share by Application (2016-2027)
Figure 70. Latin America Nasal Spray Influenza Vaccine Sales Share by Country (2016-2027)
Figure 71. Latin America Nasal Spray Influenza Vaccine Revenue Share by Country (2016-2027)
Figure 72. Mexico Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 73. Brazil Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 74. Argentina Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 75. Middle East and Africa Nasal Spray Influenza Vaccine Sales Market Share by Type (2016-2027)
Figure 76. Middle East and Africa Nasal Spray Influenza Vaccine Revenue Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Nasal Spray Influenza Vaccine Sales Market Share by Application (2016-2027)
Figure 78. Middle East and Africa Nasal Spray Influenza Vaccine Revenue Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Nasal Spray Influenza Vaccine Sales Share by Country (2016-2027)
Figure 80. Middle East and Africa Nasal Spray Influenza Vaccine Revenue Share by Country (2016-2027)
Figure 81. Turkey Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 82. Saudi Arabia Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 83. UAE Nasal Spray Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 84. Nasal Spray Influenza Vaccine Value Chain
Figure 85. Nasal Spray Influenza Vaccine Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

以下、関連資料のご紹介

鼻腔スプレー包装のグローバル市場インサイト・予測（～2027年）

Global Nasal Spray Packaging Market Insights and Forecast to 2027
QY2112C03811 2021年12月 96Pages
本調査資料は鼻腔スプレー包装の世界市場の現状について調査・分析し、2027年までの市場を予測しました。鼻腔スプレー包装の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（鼻腔スプレーポンプ、鼻腔スプレーネブライザー）、用途別市場規模（医薬品、医療、その他）、主要地域別市場規模（北米・ア...

経鼻アレルゲンブロッカーのグローバル市場インサイト・予測（～2027年）

Global Nasal Allergen Blocker Market Insights and Forecast to 2027
QY2112C03894 2021年12月 105Pages
本調査資料は経鼻アレルゲンブロッカーの世界市場の現状について調査・分析し、2027年までの市場を予測しました。経鼻アレルゲンブロッカーの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（スプレー、ゲル）、用途別市場規模（オンライン、オフライン）、主要地域別市場規模（北米・アメリカ、ヨー...

経鼻フードのグローバル市場インサイト・予測（～2027年）

Global Nasal Hoods Market Insights and Forecast to 2027
QY2112C03570 2021年12月 95Pages
本調査資料は経鼻フードの世界市場の現状について調査・分析し、2027年までの市場を予測しました。経鼻フードの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（使い捨て式、再利用可能式）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・...

伝染性ファブリキウス嚢病ワクチンのグローバル市場インサイト・予測（～2027年）

Global Infectious Bursal Disease Vaccine Market Insights and Forecast to 2027
QY2112C03867 2021年12月 113Pages
本調査資料は伝染性ファブリキウス嚢病ワクチンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。伝染性ファブリキウス嚢病ワクチンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ライブ、非アクティブ化）、用途別市場規模（動物薬局、オンライン販売、その他）、主要地...

マイコプラズマガリセプチカムワクチンのグローバル市場インサイト・予測（～2027年）

Global Mycoplasma Galliscepticum Vaccine Market Insights and Forecast to 2027
QY2112C03890 2021年12月 106Pages
本調査資料はマイコプラズマガリセプチカムワクチンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。マイコプラズマガリセプチカムワクチンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（生、不活化）、用途別市場規模（動物薬局、オンライン販売、その他）、主要地域別...

ワクチン保管用冷蔵庫＆冷凍庫のグローバル市場インサイト・予測（～2027年）

Global Refrigerators and Freezers for Vaccine Storage Market Insights and Forecast to 2027
QY2112C03733 2021年12月 129Pages
本調査資料はワクチン保管用冷蔵庫＆冷凍庫の世界市場の現状について調査・分析し、2027年までの市場を予測しました。ワクチン保管用冷蔵庫＆冷凍庫の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（アップライト型、ポータブル型、アンダーカウンター型）、用途別市場規模（病院、クリニック、その...

無針ワクチン注射器のグローバル市場インサイト・予測（～2027年）

Global Needle-Free Vaccine Injectors Market Insights and Forecast to 2027
QY2112C03573 2021年12月 109Pages
本調査資料は無針ワクチン注射器の世界市場の現状について調査・分析し、2027年までの市場を予測しました。無針ワクチン注射器の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（プレフィルドニードルフリーインジェクター、フィラブルニードルフリーインジェクター）、用途別市場規模（病院、クリニ...

生理食塩水スプレーのグローバル市場インサイト・予測（～2027年）

Global Saline Spray Market Insights and Forecast to 2027
QY2112C03924 2021年12月 112Pages
本調査資料は生理食塩水スプレーの世界市場の現状について調査・分析し、2027年までの市場を予測しました。生理食塩水スプレーの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（20ML、50ML、100ML）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米・アメリカ...

ワクチンボトル用ゴム栓のグローバル市場インサイト・予測（～2027年）

Global Rubber Stopper for Vaccine Bottles Market Insights and Forecast to 2027
QY2112C01062 2021年12月 125Pages
本調査資料はワクチンボトル用ゴム栓の世界市場の現状について調査・分析し、2027年までの市場を予測しました。ワクチンボトル用ゴム栓の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ヒト用、動物用）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米・アメリカ、ヨーロ...

オクルージョンスプレーのグローバル市場インサイト・予測（～2027年）

Global Occlusion Spray Market Insights and Forecast to 2027
QY2112C01403 2021年12月 96Pages
本調査資料はオクルージョンスプレーの世界市場の現状について調査・分析し、2027年までの市場を予測しました。オクルージョンスプレーの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（緑、赤、青、白、その他）、用途別市場規模（医療、実験、その他）、主要地域別市場規模（北米・アメリカ、ヨー...

鼻腔スプレー包装のグローバル市場インサイト・予測（～2027年） The nasal spray, which is a bottle, dropper, and TE Cap. There are two different solutions ：Spray bottles with nebulizer and spray and pump system. Market Analysis and Insights: Global Nasal Spray Packaging Market The global Nasal Spray Packaging market is valued at US$ XX million in 2020. The marke…
経鼻アレルゲンブロッカーのグローバル市場インサイト・予測（～2027年） Allergen Blocker is a product that delivers fast, effective protection against airborne allergens such as those from pollen, pets and dust mites. Allergen Blocker Air and Surface spray are safe for use on carpets, upholstery, clothes furniture & fabrics. Market Analysis and Insights: Global Nasal Al…
経鼻フードのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Nasal Hoods Market The global Nasal Hoods market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Nasal Hoods Scope and Segment Nasal Hoods market is segmented by …
トイレトレーニングスプレーのグローバル市場インサイト・予測（～2027年） Potty Training Spray is specially formulated to help train dogs to relieve themselves where you want them to. Market Analysis and Insights: Global Potty Training Spray Market The global Potty Training Spray market is valued at US$ million in 2020. The market size will reach US$ million by the end of…
オクルージョンスプレーのグローバル市場インサイト・予測（～2027年） The spray is intended for the marking of contact points on prosthetic work and crowns via a thin easily dosed color film. Market Analysis and Insights: Global Occlusion Spray Market The global Occlusion Spray market is valued at US$ million in 2020. The market size will reach US$ million by the end …